Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACOMITINIB vs DACTINOMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACOMITINIB vs DACTINOMYCIN: Safety Overview

Metric DACOMITINIB DACTINOMYCIN
Total FAERS Reports 682 2,858
Deaths Reported 325 507
Death Rate 47.7% 17.7%
Hospitalizations 168 721
Average Patient Age 64.0 yrs 18.8 yrs
% Female Patients 52.0% 65.9%
FDA Approval Date Sep 27, 2018 Approved Prior to Jan 1, 1982
Manufacturer Pfizer Laboratories Div Pfizer Inc Eugia US LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued